ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0016
-0.0001 (-5.88%)
Aug 4, 2025, 3:51 PM EDT
H&E Equipment Services Revenue
In the year 2017, ViaDerma had annual revenue of $44.69K, down -82.26%. ViaDerma had revenue of $17.89K in the quarter ending December 31, 2017, a decrease of -99.69%.
Revenue
44.69K
Revenue Growth
-99.75%
P/S Ratio
44.17
Revenue / Employee
595.88
Employees
75
Market Cap
1.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2017 | 44.69K | -207.29K | -82.26% |
| Dec 31, 2016 | 251.98K | 60.20K | 31.39% |
| Dec 31, 2015 | 191.78K | -18.82M | -98.99% |
| Dec 31, 2011 | 19.01M | -7.82M | -29.15% |
| Dec 31, 2010 | 26.83M | 1.57M | 6.20% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
ViaDerma News
- 2 months ago - ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance - GlobeNewsWire
- 1 year ago - ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria - GlobeNewsWire
- 1 year ago - ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires - GlobeNewsWire
- 1 year ago - ViaDerma Provides Highlights of Quarterly Financial Report - GlobeNewsWire
- 1 year ago - ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More - GlobeNewsWire
- 2 years ago - ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product - GlobeNewsWire
- 2 years ago - ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product - GlobeNewsWire
- 2 years ago - ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development - GlobeNewsWire